5-min. Genomic DNA Prep for PCR
- Known as:
- 5-min. Genomic Desoxyribonucleic acid Prep PCR test kit
- Catalog number:
- P930-5
- Product Quantity:
- 5rxn
- Category:
- -
- Supplier:
- 101 Bio.
- Gene target:
- 5-min. Genomic DNA Prep for PCR
Related genes to: 5-min. Genomic DNA Prep for PCR
- Gene:
- PREP NIH gene
- Name:
- prolyl endopeptidase
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 6q21
- Locus Type:
- gene with protein product
- Date approved:
- 1996-03-12
- Date modifiied:
- 2016-10-05
Related products to: 5-min. Genomic DNA Prep for PCR
Related articles to: 5-min. Genomic DNA Prep for PCR
- Long-acting (LA) injectable pre-exposure prophylaxis (PrEP) expands HIV prevention choice beyond daily oral tenofovir-based regimens and may improve persistence by decoupling protection from daily pill-taking. - Source: PubMed
Publication date: 2026/06/04
Raccagni Angelo RobertoCastagna AntonellaNozza Silvia - To assess the current levels of knowledge, attitudes, practices (KAP), and institutional support regarding Chemical, Biological, Radiological, and Nuclear (CBRN) disaster preparedness among anesthesia professionals in India, and to identify predictors and barriers to effective readiness. - Source: PubMed
Publication date: 2026/06/04
Gondode Prakash GyandevDuggal SakshiMalviya AmitSingh RamPrakash AvinashAsai OmshubhamGupta ParulShah Jitendra - When large-scale disasters exhaust civilian federal agencies' assets, the U.S. Federal Emergency Management Agency (FEMA) can issue mission assignments to the Department of War (DoW) to leverage its unique, self-sustaining logistical and operational capabilities. - Source: PubMed
Publication date: 2026/06/04
Post EmilyMorocho EileenAllen ShaunCox CarlyLovett KaitlinChambers JamesFreeman Jeffrey - Mutations in the KIT and PDGFRA proto-oncogenes are key drivers in gastrointestinal stromal tumors (GIST) and guide targeted therapy. While DNA-based next-generation sequencing (NGS) is standard for mutation detection, RNA sequencing (RNA-Seq) may offer complementary advantages. This study evaluates RNA-Seq performance and presents molecular epidemiologic data from a large DNA-sequenced GIST cohort. RNA-Seq was performed on 24 GIST cases previously analyzed by DNA-based NGS (16 KIT mutants, 5 PDGFRA mutants, 3 wild-type) using the Agilent SureSelectXT RNA Direct Library Prep Kit and an in-house analysis pipeline. RNA-Seq was successful in 21 cases, identifying 13 of 14 KIT mutations and all PDGFRA mutations, including single nucleotide variants (SNV), insertions, and in-frame deletions (3-27 bp). One complex 45 bp deletion-insertion was not detected, though low-level evidence (<10% of reads) was present. Separately, DNA-based NGS results from 579 GIST cases were reviewed to assess mutation prevalence and clinicopathologic associations. Mutations were found in 83.2% of cases (403 KIT, 79 PDGFRA), with secondary KIT mutations in 6.0%. Mutation site correlated with tumor location and patient age; secondary mutations were more frequent in non-gastric tumors. RNA-Seq demonstrates high accuracy for detecting clinically relevant KIT and PDGFRA mutations and may complement DNA-based profiling. The DNA cohort provides broader context for mutation prevalence and patterns in clinical practice. - Source: PubMed
Publication date: 2026/06/03
Jaladi SoumyaAlvand SabaPitel Beth AVoss Jesse SMopuri RohiniFadra NumrahSunder ShamAtiq Mazen ADavila JaimeGupta SounakKipp Benjamin RHalling Kevin C - - Source: PubMed
Publication date: 2026/06/03
Gibson AlexanderLawrence MadeleineChauhan AlokSmith KatieBlaise Benjamin J